● Recruiting

Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus

Condition: Discoid Lupus Erythematosus · Sponsor: Innovaderm Research Inc.

PhasePhase 2

Planned participants20

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This study is a single-blind, intraindividual study to evaluate the efficacy of ruxolitinib 1.5 % cream in adult subjects with discoid lupus erythematosus.

This description comes directly from the study's public registry record.

Talk to the study team

Fareheen Chowdhury · 514-521-4285 · fchowdhury@innovaderm.com

Always discuss trial participation with your own doctor first.

Locations (2)

INNO-6051 Site 03	Fredericton, New Brunswick, Canada	Recruiting
Innovaderm Research Inc.	Montreal, Quebec, Canada	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06261021